CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of DYP688 as a single agent in patients with metastatic uveal melanoma (MUM) and other melanomas harboring GNAQ/11 mutations....
Phase 1, Phase 2
New York, New York, United States and 10 other locations
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma...
Phase 2
Manhasset, New York, United States and 24 other locations
This is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma....
Phase 1
New York, New York, United States and 1 other location
ATLAS-IT-05 is an open-label, single-arm study in patients with advanced melanoma accessible for injections (cutaneous, subcutaneous, lymph ...
Phase 2
New York, New York, United States and 9 other locations
ipilimumab is a safe and effective treatment that causes few or mild side effects for locally advanced or metastatic, unresectable, refractory melanoma...
Phase 2
New York, New York, United States and 9 other locations
therapy per local standard of care (SoC), best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma...
Phase 2, Phase 3
New York, New York, United States and 70 other locations
cell death protein-1 (PD-1) inhibitor, in patients with metastatic melanomas or advanced solid tumors. Our hypothesis is that restoration of...
Phase 1, Phase 2
New York, New York, United States and 20 other locations
This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma...
Phase 2
New York, New York, United States and 43 other locations
of ANV419 with anti-PD1 antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma...
Phase 1, Phase 2
Morristown, New York, United States of America and 24 other locations
This is an open label study evaluating lifileucel (LN-144) in patients with melanoma brain metastases....
Phase 1
New York, New York, United States
Clinical trials
Research sites
Resources
Legal